tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Karen Koski, 6 are a HOLD (46.15%), 1 are a SELL (7.69%), 6 are a BUY (46.15%).
Analyst Karen Koski, carries an average stock price target met ratio of 88.89% that have a potential upside of 41.75% achieved within 342 days.
Karen Koski’s has documented 21 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.
Analyst best performing recommendations are on AXDX (ACCELERATE DIAGNOSTICS).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$5
$3.92 (362.96%)
$3
1 years 8 months 4 days ago
(30-Jul-2024)
6/6 (100%)
$0.11 (2.25%)
16
Hold
2 years 7 months 19 days ago
(15-Aug-2023)
3/4 (75%)
$-3.75 (-34.88%)
38
Hold
$7500
3 years 8 months 27 days ago
(07-Jul-2022)
3/5 (60%)
$3649 (94.75%)
390
Buy
$15000
5 years 4 months 29 days ago
(05-Nov-2020)
1/1 (100%)
$7050 (88.68%)
177
Hold
$200
$194.55 (3569.72%)
$200
8 years 10 months 27 days ago
(08-May-2017)
2/3 (66.67%)
$64.67 (8.94%)
172
What Year was the first public recommendation made by Karen Koski?
